Parallel Advisors’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.9K Buy
2,246
+2,141
+2,039% +$13.1K ﹤0.01% 2526
2026
Q1
$803 Hold
105
﹤0.01% 3576
2025
Q4
$1.02K Hold
105
﹤0.01% 3289
2025
Q3
$440 Sell
105
-607
-85% -$3.88K ﹤0.01% 3346
2025
Q2
$6.61K Buy
712
+209
+42% +$1.82K ﹤0.01% 2642
2025
Q1
$4.9K Buy
503
+9
+2% +$111 ﹤0.01% 2690
2024
Q4
$5.98K Hold
494
﹤0.01% 2572
2024
Q3
$5.41K Buy
494
+150
+44% +$1.52K ﹤0.01% 2584
2024
Q2
$3.1K Buy
+344
New +$2.4K ﹤0.01% 2674
2024
Q1
Sell
-150
Closed -$1.26K 3400
2023
Q4
$1.26K Buy
150
+144
+2,400% +$1.67K ﹤0.01% 2894
2023
Q3
$103 Hold
6
﹤0.01% 3280
2023
Q2
$139 Sell
6
-4
-40% -$78 ﹤0.01% 3264
2023
Q1
$177 Hold
10
﹤0.01% 3291
2022
Q4
$272 Sell
10
-4
-29% -$83 ﹤0.01% 3139
2022
Q3
$0 Buy
14
+8
+133% +$153 ﹤0.01% 3431
2022
Q2
$0 Buy
+6
New +$99 ﹤0.01% 3289

Other funds holding REPL

Parallel Advisors's REPL Position: Q2 2026 in Review

Parallel Advisors increased its Replimune Group (REPL) stake by 2,039% in Q2 2026, buying an estimated $13.1K and bringing the position to 2,246 shares worth $24.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2526.

Parallel Advisors first reported a position in REPL in Q2 2022 and has held it in 16 quarters since. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Parallel Advisors held 2,246 shares of Replimune Group worth $24.9K as of Q2 2026.
  • Parallel Advisors bought 2,141 Replimune Group shares in Q2 2026, an estimated $13.1K.
  • Replimune Group made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2526 holding.
  • Parallel Advisors first reported a position in Replimune Group in Q2 2022 and has held it in 16 quarters since.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.